Stem Cells Dev. 2010 Jul; 19(7) : 1017-23. Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L. Farber Institute for Neurosciences, Department of Neurology, Thomas Jefferson University , Philadelphia, PA 19107, USA. Abstract Cell replacement therapy could…

Neuropharmacology. 2010 May; 58(6) : 855-64. Epub 2010 Feb 8. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Naegele JR, Maisano X, Yang J, Royston S, Ribeiro E. Department of Biology and Program in Neuroscience and Behavior, Hall Atwater Laboratory, 52 Lawn Avenue, Wesleyan University, Middletown, CT 06459, USA.…

Biochem Biophys Res Commun. 2010 May 21; 396(1) : 152-6. Towards stem cell replacement therapies for Parkinson’s disease. Arenas E. Laboratory of Molecular Neurobiology, MBB, Center for Developmental Biology and Regenerative Medicine, Scheelevagen 1, 17177 Stockholm, Sweden. Ernest.Arenas@ki.se Abstract Current therapeutic approaches for Parkinson’s disease (PD) provide symptomatic relief but none of them change the…

Cytotherapy. 2010 Apr; 12(2) : 226-37. Gene therapy in hemiparkinsonian rhesus monkeys: long-term survival and behavioral recovery by transplantation of autologous human tyrosine hydroxylase-expressing neural stem cells. Xu Q, Jiang X, Ke Y, Zhang S, Xu R, Zeng Y. Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China 510282. Abstract BACKGROUND AIMS: Neural stem…

Rejuvenation Res. 2010 Apr-Jun; 13(2-3) : 188-94. Cellular repair in the parkinsonian nonhuman primate brain. Redmond DE Jr, Weiss S, Elsworth JD, Roth RH, Wakeman DR, Bjugstad KB, Collier TJ, Blanchard BC, Teng YD, Synder EY, Sladek JR Jr. Department of Psychiatry and Neurosurgery, Yale University School of Medicine, New Haven, Connecticut 06511, USA. eugene.redmond@yale.edu…

J Vasc Interv Radiol. 2010 Apr; 21(4) : 443-51. Intraarterial autologous implantation of adult stem cells for patients with Parkinson disease. Brazzini A, Cantella R, De la Cruz A, Yupanqui J, León C, Jorquiera T, Brazzini M, Ortega M, Saenz LN. Brazzini Institute of Radiology, Lima 27, Perú. research@brazzini.com Erratum in: Vasc Interv Radiol. 2010…

Adv Exp Med Biol. 2010; 671 : 117-30. Gene- and cell-based approaches for neurodegenerative disease. Urbaniak Hunter K, Yarbrough C, Ciacci J. Department of Radiation Oncology, Univesity of Michigan, Ann Arbor, Michigan, USA. kurbania@med.umich.edu Abstract Neurodegenerative diseases comprise an important group ofchronic diseases that increase in incidence with rising age. In particular, the two most…

Neuropharmacology. 2010 May; 58(6) : 855-64. Epub 2010 Feb 8. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Naegele JR, Maisano X, Yang J, Royston S, Ribeiro E. Department of Biology and Program in Neuroscience and Behavior, Hall Atwater Laboratory, 52 Lawn Avenue, Wesleyan University, Middletown, CT 06459, USA.…

Stem Cells Dev. 2010 Mar; 19(3) : 311-20. Stem cell therapy for Parkinson’s disease: a road map for a successful future. Vidaltamayo R, Bargas J, Covarrubias L, Hernández A, Galarraga E, Gutiérrez-Ospina G, Drucker-Colin R. Depto de Neurociencias and Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, México. Abstract Cell transplant therapy for Parkinson’s…

Regen Med. 2010 Mar; 5(2) : 267-78. Stem cell-derived dopamine neurons for brain repair in Parkinson’s disease. Fricker-Gates RA, Gates MA. Keele University, Keele, Staffordshire, UK. r.a.fricker-gates@hfac.keele.ac.uk Abstract One of the prospects for a curative treatment for Parkinson’s disease is to replace the lost dopaminergic neurons. Preclinical and clinical trials have demonstrated that dissected fetal…